Our data unequivocally provide evidence that the IL-12/IL-23p40-mediated amelioration of AD pathology previously described by us7,8 is mediated solely through IL-12 signaling, whereas IL-23 plays no role. The gene discussed is IL23A; the disease is Alzheimer disease.